CGAP is an ecosystem composed of several independent programs and services that collaborate in useful ways, including, among others, the CGAP bioinformatics pipeline and the user-facing CGAP portal. Users may freely use CGAP for non-commercial purposes as long as they properly cite it, except that some of the resources in the bioinformatics pipeline, including CADD, ClinVar, OMIM, Polyphen-2, REVEL, RVIS, Brain Atlas, MGI, UCSC Genome Browser, and FlyBase may have additional restrictions. These resources are variously restricted by use categories such as academic, educational, research, non-profit, or non-commercial in ways that may or may not align well with your intended use. Harvard cannot and do not grant any waiver to such restrictions. You must contact the corresponding license owners on all relevant components if you desire clarification or additional permissions.
You acknowledge that the Computational Genome Analysis Platform (“CGAP”), including without limitation, the database of information contained therein, is experimental and academic in nature, and is not licensed by the U.S. Food and Drug administration or any other regulatory body. CGAP is provided on an "as is" and “as available” basis with all faults, without warranty or representation of any kind, express or implied. Harvard disclaims all warranties and representations, express or implied, with respect to CGAP, including without limitation, any warranties of title, merchantability, fitness for a particular purpose and non-infringement of third-party rights. This disclaimer applies to the fullest extent possible. Harvard does not warrant that CGAP will meet your requirements or that the use of CGAP will be free of infection or viruses, error-free, uninterrupted, secure or will produce accurate results. You shall bear total and exclusive responsibility and risk for the use of CGAP. You shall be solely responsible for any resulting damage to your computer systems or loss of data. If you are dissatisfied with CGAP, or with any of these terms, your sole and exclusive remedy is to discontinue using CGAP. Although this software is available under an open-source license, its primary and intended function is to support our major projects, Fourfront and CGAP, which are offered as services. We do not intend by merely storing it in this form to suggest its usability out of context, nor to offer any active support for other uses.